These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

683 related items for PubMed ID: 19524652

  • 1. CDs as solubilizers: effects of excipients and competing drugs.
    Jansook P, Loftsson T.
    Int J Pharm; 2009 Sep 08; 379(1):32-40. PubMed ID: 19524652
    [Abstract] [Full Text] [Related]

  • 2. Self-assembly of cyclodextrin complexes: aggregation of hydrocortisone/cyclodextrin complexes.
    Messner M, Kurkov SV, Brewster ME, Jansook P, Loftsson T.
    Int J Pharm; 2011 Apr 04; 407(1-2):174-83. PubMed ID: 21237259
    [Abstract] [Full Text] [Related]

  • 3. Self-assembled cyclodextrin aggregates and nanoparticles.
    Messner M, Kurkov SV, Jansook P, Loftsson T.
    Int J Pharm; 2010 Mar 15; 387(1-2):199-208. PubMed ID: 19963052
    [Abstract] [Full Text] [Related]

  • 4. Cyclodextrin-poloxamer aggregates as nanocarriers in eye drop formulations: dexamethasone and amphotericin B.
    Jansook P, Pichayakorn W, Muankaew C, Loftsson T.
    Drug Dev Ind Pharm; 2016 Sep 15; 42(9):1446-54. PubMed ID: 26765786
    [Abstract] [Full Text] [Related]

  • 5. gammaCD/HPgammaCD: synergistic solubilization.
    Jansook P, Loftsson T.
    Int J Pharm; 2008 Nov 03; 363(1-2):217-9. PubMed ID: 18691643
    [Abstract] [Full Text] [Related]

  • 6. Cyclodextrins: Efficient biocompatible solubilizing excipients for bromhexine liquid and semi-solid drug delivery systems.
    Stojanov M, Nielsen HM, Larsen KL.
    Int J Pharm; 2012 Jan 17; 422(1-2):349-55. PubMed ID: 22027391
    [Abstract] [Full Text] [Related]

  • 7. Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: formulation of dorzolamide eye drop microparticle suspension.
    Jansook P, Stefánsson E, Thorsteinsdóttir M, Sigurdsson BB, Kristjánsdóttir SS, Bas JF, Sigurdsson HH, Loftsson T.
    Eur J Pharm Biopharm; 2010 Oct 17; 76(2):208-14. PubMed ID: 20637867
    [Abstract] [Full Text] [Related]

  • 8. Cyclodextrins--enabling excipients: their present and future use in pharmaceuticals.
    Thompson DO.
    Crit Rev Ther Drug Carrier Syst; 1997 Oct 17; 14(1):1-104. PubMed ID: 9043816
    [Abstract] [Full Text] [Related]

  • 9. Effect of pH and water-soluble polymers on the aqueous solubility of nimesulide in the absence and presence of beta-cyclodextrin derivatives.
    Alexanian C, Papademou H, Vertzoni M, Archontaki H, Valsami G.
    J Pharm Pharmacol; 2008 Nov 17; 60(11):1433-9. PubMed ID: 18957163
    [Abstract] [Full Text] [Related]

  • 10. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM, Elkheshen SA, Ghorab MM.
    Eur J Pharm Biopharm; 2008 Nov 17; 70(3):819-27. PubMed ID: 18655829
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Development of a cyclodextrin-based aqueous cyclosporin A eye drop formulations.
    Jóhannsdóttir S, Jansook P, Stefánsson E, Loftsson T.
    Int J Pharm; 2015 Sep 30; 493(1-2):86-95. PubMed ID: 26220650
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The self-assemble of natural cyclodextrins in aqueous solutions: Application of miniature permeation studies for critical aggregation concentration (cac) determinations.
    Saokham P, Sá Couto A, Ryzhakov A, Loftsson T.
    Int J Pharm; 2016 May 30; 505(1-2):187-93. PubMed ID: 27021466
    [Abstract] [Full Text] [Related]

  • 15. Aggregation of cyclodextrins as an important factor to determine their complexation behavior.
    Bikádi Z, Kurdi R, Balogh S, Szemán J, Hazai E.
    Chem Biodivers; 2006 Nov 30; 3(11):1266-78. PubMed ID: 17193241
    [Abstract] [Full Text] [Related]

  • 16. Effect of γ-cyclodextrin on solubilization and complexation of irbesartan: influence of pH and excipients.
    Muankaew C, Jansook P, Stefánsson E, Loftsson T.
    Int J Pharm; 2014 Oct 20; 474(1-2):80-90. PubMed ID: 25128698
    [Abstract] [Full Text] [Related]

  • 17. yCD/HPyCD mixtures as solubilizer: solid-state characterization and sample dexamethasone eye drop suspension.
    Jansook P, Ritthidej GC, Ueda H, Stefánsson E, Loftsson T.
    J Pharm Pharm Sci; 2010 Oct 20; 13(3):336-50. PubMed ID: 21092707
    [Abstract] [Full Text] [Related]

  • 18. Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use.
    Holvoet C, Vander Heyden Y, Plaizier-Vercammen J.
    Drug Dev Ind Pharm; 2005 Jul 20; 31(6):567-75. PubMed ID: 16109630
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of a sulfobutyl ether beta-cyclodextrin as a solubilizing/stabilizing agent for several drugs.
    Ueda H, Ou D, Endo T, Nagase H, Tomono K, Nagai T.
    Drug Dev Ind Pharm; 1998 Sep 20; 24(9):863-7. PubMed ID: 9876538
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.